Safety study, anti-inflammatory and antioxidant action of drug caramel with polyhexamethylene guanidine phosphate
Keywords:PHMGP, Dosage form caramel guamel, Acute toxicity, Irritating, Anti-inflammatory and antioxidant activity
Background: Among the new antiseptic medicines, most meeting modern requirements in terms of treatment of microbial invasion are one of the leading positions occupied by the polymeric guanidine compound. Polyhexamethylene guanidine phosphate (PHMGP) has a wide spectrum of antimicrobial activity and practical absence of toxicity. We have developed a new dosage form caramel “Guamel'” with the active pharmaceutical ingredient.
Methods: on white rats of both sexes were studied parameters of acute toxicity and irritant dosage form caramel “Guamel'”, as well as anti-inflammatory and antioxidant effects.
Results: It was found that the PHMGP developed drug caramel does not have skin-resorptive and allergenic action. Study of acute toxicity on white rats showed harmlessness studied dosage form PHMGP. It was found that a single oral administration to laboratory animals in drug caramel maximum allowable amount and cutaneous application does not lead to death during a 48 hour period of observation, does not cause visible changes in the basic physiological processes and does not affect the function of vital organs. On carrageenan model of inflammation it proved that the drug caramel with PHMGP exhibits anti-inflammatory effect, such a superior drug-referent "Septolete". It is also found to have developed in preparation of antioxidant activity in the inhibition of oxidative protein modifications also significantly superior to the reference drug.
Conclusions: The developed dosage form caramel “Guamel'” for external use of the safety performance meets the requirements for such drugs. The developed dosage form caramel “Guamel'” exhibits high anti-inflammatory and antioxidant activity, which is the force exceeds the reference value. All of this is experimental rationale for the industrial production of this dosage form caramel “Guamel'”.
Pavlichko S. Principles of adjusting dosage forms of children's. Pharmaceutical Journal. 2000;5:47-51.
On approval of the classifier dosage forms. The Ministry of Health of Ukraine from number 235. Available at http://www.yur-info.org.ua/doc/1685064/Pro-zatverdzhennia-Klasifikatora-likarskikh-form.
Magomedov G, Oleynikov A, Plotnikov I. Confectionery. Bulletin VGUIT. 2002;3:59-61.
Marshalkin G. Confectionery. Moscow, Kolos; 1994:272.
Sidorenko M, Skobelskaya Z, Kondakova I. Pat. 2182435 RU, MKI A23 G3/00. A process for preparing caramel. № 2182435, appl. 14/06/01; publ. 20.05.02, Bul. Number 14.
Sidorenko M, Skobelskaya Z, Kondakova I. Effect of pH on the kinetics of caramel it wet during storage. Storage and processing of agricultural raw materials, 2000;8;23-5.
Dragilev A, Kondakov I, Masolova V. Technological instruction on production of caramel. All-Union Scientific Research Institute of the confectionery industry, Moscow. 1990:90.
Shterman S. Analysis and substantiation of technological indicators of the main raw material for the production of caramel. Dissertation of the candidate of pharmaceutical sciences, Moscow. 2002:155.
Randonus J, Bernard J, Janssen H. Effect of oligomeric and polymeric adiitives on glass transition, viscosity and crystallization of amorphous isomalt. Food research International. 2000;33:41-51.
Yakimov A. Substantiation of technology research and health care facilities based confectionery. Dissertation of the candidate of pharmaceutical sciences. Technology of medicines and industrial pharmacy, Kiev. 2001:19.
Sidorenko M. Development of new types of candy by modeling its structural and mechanical characteristics. Dissertation of the candidate of technical sciences, Moscow. 2003:306.
Stefanova A. Guidelines preclinical studies of drugs. Psychology, Avicenna. 2002:568.
Alexeyeva O. Guidelines on the assessment of the allergenic properties of pharmacological agents. Ed. Moscow, Medicine. 1988:19.
Kozhemyakin Y, Khromov A, Filonenko M, Sayretdinova T. Scientific and practical advice on keeping laboratory animals and work with him. Kyiv. 2002:155.
The issuance of permission for the use and introduction of drugs. Pharmacologically Journal. 1996;1:S12-20.
Kukes V, Bulaev V, Kolkhir V. Guidelines for preclinical studies of new drugs developed from natural raw materials. Manual on experimental (preclinical) study of new pharmacological substances. Moscow, Russian Federation –Minzdrav. 2005:348s.
Belenichev I, Gubsky Y, Dunaev V. Methods for assessing antioxidant chemical substance when initiating free-radical processes in experiments in vitro. Guidelines. Kyiv: State Pharmacopoeia Center the Ministry of Health of Ukraine; 2002:26.